Akamai files Form 144 for planned insider stock sales

Akamai Technologies, Inc. reported proposed insider sales in a Form 144 notice.

Accepted by SEC EDGAR 03/04/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Akamai Technologies, Inc. reported proposed insider sales in a Form 144 notice. The filing lists planned dispositions tied to equity compensation lapses on 02/19/2025 (6,749 shares), 02/21/2025 (1,893 shares), 03/04/2025 (3,186 shares) and 03/07/2025 (1,722 shares). The filing is a routine regulatory notice of intended sales by holders.

Insights

Insider Transactions Specialist

Form 144 lists planned sales tied to equity compensation lapses on specific dates.

The excerpt shows planned dispositions associated with equity compensation lapses on 02/19/2025 (6,749 shares), 02/21/2025 (1,893 shares), 03/04/2025 (3,186 shares) and 03/07/2025 (1,722 shares). These entries are presented as securities to be sold rather than closed transactions.

Cash‑flow treatment and buyer types are not disclosed in the provided excerpt, and timing beyond the listed dates is not specified in the provided excerpt. Subsequent securities filings may report actual sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Akamai's Form 144 (AKAM) list?

The Form 144 lists proposed dispositions tied to equity compensation lapses on 02/19/2025 (6,749 shares), 02/21/2025 (1,893 shares), 03/04/2025 (3,186 shares) and 03/07/2025 (1,722 shares). It is a notice of intended sales.

Does the Form 144 show completed sales for AKAM?

No, this filing lists intended sales associated with equity compensation lapse dates; it does not record completed market transactions. Actual sale confirmations would appear in later trade reports or Form 4/5 filings.

Who appears to be selling shares in the Akamai filing?

The excerpt ties the listed securities to equity compensation lapses, implying holders of compensation awards. The filing does not name individual sellers or entities in the provided excerpt.

How many total shares are listed for proposed sale in the excerpt?

The excerpt lists four line items totaling 13,550 shares when summed: 6,749; 1,893; 3,186; and 1,722. The filing presents these as planned dispositions on the listed dates.

What form of securities are referenced in Akamai's Form 144?

The filing references Common stock tied to equity compensation events (performance stock lapse and restricted stock lapse) on the listed dates. No other instrument types are shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001810228
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKAMAI TECHNOLOGIES INC
SEC File Number	000-27275
Address of Issuer	145 BROADWAY CAMBRIDGE MASSACHUSETTS 02142
Phone	6174443000
Name of Person for Whose Account the Securities are To Be Sold	Sundaram Mani
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	13550	1371927.00	144888114	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2025	Performance Stock Lapse	Akamai Technologies, Inc			6749	02/19/2025	Equity Compensation
Common	02/21/2025	Restricted Stock Lapse	Akamai Technologies, Inc			1893	02/21/2025	Equity Compensation
Common	03/04/2025	Restricted Stock Lapse	Akamai Technologies, Inc			3186	03/04/2025	Equity Compensation
Common	03/07/2025	Restricted Stock Lapse	Akamai Technologies, Inc			1722	03/07/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares sold in account titled THE MMMM FAMILY LIVING TRUST, M SUNDARAM & M RAMAKRISHNAN TTEE and may be sold over various dates.
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	MANI SUNDARAM TTEE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)